BOHLIN GAREN G - Insider Non-Derivative Transactions at Karyopharm Therapeutics Inc. (KPTI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 12, 2023, BOHLIN GAREN G's relationship to Karyopharm Therapeutics Inc. (KPTI) is Director, and currently has 45,140 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KPTI insiders.
Data Source: SEC.
BOHLIN GAREN G - Insider Non-Derivative Transactions at KPTI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 13, 2023 | P -- (Common Stock) | 41140 | 1.22 | 45140 |